McGill CBD research collaboration helping develop new therapies for treating chronic pain

News

Published: 10Feb2021

Important pain research from the Sharif Lab is helping develop cannabidiol (CBD) therapies to treat chronic pain.

US company Desert Harvest has teamed up with the McGill Research Centre for Cannabis to fund a pre-clinical study to determine if their plant-based CBD Aloe Vera product can help people suffering from interstitial cystitis, a chronic bladder condition. Evidence suggests CBD is beneficial for treating a wide range of clinical conditions and could be an effective alternative to opioid treatments. This study is an example of how knowledge from our laboratories benefits the community at large. 

To learn more, check out these articles:

Desert Harvest Announces Study About CBD and Cystitis (cbdtoday.com)

Aloe vera extract producer funds McGill CBD pain research - Mugglehead Magazine

Photo (above): The Sharif Lab members at McGill Pain Day, January 23, 2020

Back to top